(Reuters) - Generic drugmaker Apotex Inc's Chief Executive Jeremy Desai resigned and will be replaced by his predecessor and co-founder Jack Kay, the Globe and Mail reported on Friday.
Desai "resigned to pursue other opportunities. His notice is effective immediately," the newspaper said, citing a written statement from Apotex.
The company's billionaire-founder Barry Sherman, who died in December, failed to implement a succession plan, potentially leaving it vulnerable to takeover approaches, Reuters had reported.
Apotex was not immediately available for comment.
(Reporting by John Benny in Bengaluru; Editing by Anil D'Silva)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app